Pancreatic Cancer Research

ResearcherUniversitätsmedizin RostockActive in the last 2 years

Larissa Henze

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6104-3643; OpenAlex author ID A5045384350. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 3

  1. Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116… Co-author DOI 10.1007/s00432-024-05827-x↗
  2. Multicohort study testing the generalisability of the SASKit-ML stroke and PDAC prognostic model pipeline to other chronic diseases. First author DOI 10.1136/bmjopen-2024-088181↗
  3. Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidity and ageing/cellular senescence (SASKi… Co-author DOI 10.1136/bmjopen-2020-039560↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Georg Fuellen · 2 shared papers, 2020–2024 · strength 0.35
  2. Daniel H. Palmer · 2 shared papers, 2020–2024 · strength 0.35
  3. Hugo Murua Escobar · 2 shared papers, 2020–2024 · strength 0.35
  4. Volker Kunzmann · 1 shared paper, 2024 · strength 0.16
  5. Oliver Waidmann · 1 shared paper, 2024 · strength 0.16
  6. Annika Kurreck · 1 shared paper, 2024 · strength 0.16
  7. Dominik Paul Modest · 1 shared paper, 2024 · strength 0.16
  8. Volker Heinemann · 1 shared paper, 2024 · strength 0.16
  9. Helmut Oettle · 1 shared paper, 2024 · strength 0.16
  10. Olaf Wolkenhauer A · 1 shared paper, 2020 · strength 0.09
  11. Falko Lange · 1 shared paper, 2020 · strength 0.09
  12. Robert Jaster · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.